CRNX's three largest insider shareholders as of April 17, 2026 are Advisors Llc Perceptive (TenPercentOwner, 5.32Mn shares), Richard Scott Struthers (President Ceo, 661.21K shares), Richard Scott Struthers (President Ceo, 661.21K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Advisors Llc Perceptive | - | 0 | 5,321,032 | 18 Apr, 2022 |
| Richard Scott Struthers | President Ceo | 0 | 661,205 | 16 May, 2025 |
| Richard Scott Struthers | President Ceo | 0 | 661,205 | 16 May, 2025 |
| Richard Scott Struthers | President Ceo | 404,778 | 0 | 18 Mar, 2026 |
| Richard Scott Struthers | President Ceo | 404,778 | 0 | 18 Mar, 2026 |
| Richard Scott Struthers | President Ceo | 0 | 270,000 | 09 Sep, 2021 |
| Richard Scott Struthers | President Ceo | 0 | 270,000 | 09 Sep, 2021 |
| Ajay Madan | Chief Development Officer | 176,995 | 0 | 02 Mar, 2022 |
| Ajay Madan | Chief Development Officer | 176,995 | 0 | 02 Mar, 2022 |
| Stephen F. Betz | Chief Scientific Officer | 137,101 | 0 | 18 Mar, 2026 |
| Stephen F. Betz | Chief Scientific Officer | 123,583 | 0 | 17 Feb, 2022 |
| Wendall Wierenga | - | 116,146 | 0 | 13 Jun, 2025 |
| Jeff E. Knight | Chief Operating Officer | 112,018 | 0 | 18 Mar, 2026 |
| Marc Wilson | Cfo | 111,092 | 0 | 30 Sep, 2024 |
| Marc Wilson | Cfo | 111,092 | 0 | 30 Sep, 2024 |
| Richard Scott Struthers | President Ceo | 0 | 110,000 | 14 Feb, 2024 |
| Richard Scott Struthers | President Ceo | 0 | 110,000 | 14 Feb, 2024 |
| Richard Scott Struthers | President Ceo | 0 | 106,000 | 30 Sep, 2025 |
| Richard Scott Struthers | President Ceo | 0 | 106,000 | 30 Sep, 2025 |
| Jeff E. Knight | Chief Dev. Operating Officer | 105,289 | 0 | 10 Apr, 2026 |
| Richard Scott Struthers | President Ceo | 0 | 100,000 | 04 Dec, 2024 |
| Richard Scott Struthers | President Ceo | 0 | 100,000 | 04 Dec, 2024 |
| Tobin Schilke | Chief Financial Officer | 78,121 | 0 | 04 Mar, 2026 |
| Tobin Schilke | Chief Financial Officer | 78,121 | 0 | 04 Mar, 2026 |
| Dana Pizzuti | Chief Med And Dev Officer | 66,837 | 0 | 03 Dec, 2025 |
| Dana Pizzuti | Chief Med And Dev Officer | 66,837 | 0 | 03 Dec, 2025 |
| Alan Seth Krasner | Chief Medical Officer | 43,210 | 0 | 19 Oct, 2023 |
| Alan Seth Krasner | Chief Medical Officer | 43,210 | 0 | 19 Oct, 2023 |
| Isabel Kalofonos | Chief Commercial Officer | 34,834 | 0 | 25 Feb, 2026 |
| Isabel Kalofonos | Chief Commercial Officer | 34,834 | 0 | 25 Feb, 2026 |
| James Hassard | Chief Commercial Officer | 29,259 | 0 | 09 Jul, 2024 |
| James Hassard | Chief Commercial Officer | 29,259 | 0 | 09 Jul, 2024 |
| Matthew K Fust | - | 22,836 | 0 | 30 Sep, 2025 |
| Matthew K Fust | - | 22,836 | 0 | 30 Sep, 2025 |
| Weston Nichols | - | 16,300 | 0 | 13 Jun, 2025 |
| Camille L Bedrosian | - | 16,300 | 0 | 13 Jun, 2025 |
| Caren Deardorf | - | 16,300 | 0 | 13 Jun, 2025 |
| Coelho Rogerio Vivaldi | - | 16,300 | 0 | 13 Mar, 2026 |
| Coelho Rogerio Vivaldi | - | 16,300 | 0 | 13 Mar, 2026 |
| Weston Nichols | - | 16,300 | 0 | 13 Jun, 2025 |
| Stephanie Okey | - | 13,300 | 0 | 04 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 08 Apr, 2026 | Jeff E. Knight | Common Stock | A | 49,474 | $23.98 | 161,492 | D | M |
| 08 Apr, 2026 | Jeff E. Knight | Common Stock | A | 9,624 | $20.02 | 171,116 | D | M |
| 08 Apr, 2026 | Jeff E. Knight | Common Stock | A | 19,336 | $19.64 | 190,452 | D | M |
| 08 Apr, 2026 | Jeff E. Knight | Common Stock | D | 85,163 | $40.10 | 105,289 | D | S |
| 08 Apr, 2026 | Jeff E. Knight | Stock Option (Right to Buy) | D | 49,474 | $0.00 | 63,027 | D | M |
| 08 Apr, 2026 | Jeff E. Knight | Stock Option (Right to Buy) | D | 9,624 | $0.00 | 10,589 | D | M |
| 08 Apr, 2026 | Jeff E. Knight | Stock Option (Right to Buy) | D | 19,336 | $0.00 | 65,977 | D | M |
| 16 Mar, 2026 | Jeff E. Knight | Common Stock | D | 5,950 | $37.11 | 115,979 | D | S |
| 16 Mar, 2026 | Richard Scott Struthers | Common Stock | D | 13,196 | $37.11 | 413,563 | D | S |
| 16 Mar, 2026 | Stephen F. Betz | Common Stock | D | 6,371 | $37.11 | 141,342 | D | S |
| 16 Mar, 2026 | Richard Scott Struthers | Common Stock | D | 8,785 | $37.77 | 404,778 | D | S |
| 16 Mar, 2026 | Jeff E. Knight | Common Stock | D | 3,961 | $37.77 | 112,018 | D | S |
| 16 Mar, 2026 | Stephen F. Betz | Common Stock | D | 4,241 | $37.77 | 137,101 | D | S |
| 12 Mar, 2026 | Coelho Rogerio Vivaldi | Common Stock | D | 4,477 | $36.08 | 16,823 | D | S |
| 12 Mar, 2026 | Coelho Rogerio Vivaldi | Common Stock | D | 523 | $36.77 | 16,300 | D | S |
| 03 Mar, 2026 | Tobin Schilke | Common Stock | D | 6,713 | $39.67 | 78,121 | D | S |
| 23 Feb, 2026 | Tobin Schilke | Common Stock | A | 32,000 | $0.00 | 84,834 | D | A |
| 23 Feb, 2026 | Richard Scott Struthers | Common Stock | A | 62,000 | $0.00 | 426,759 | D | A |
| 23 Feb, 2026 | Isabel Kalofonos | Common Stock | A | 34,000 | $0.00 | 34,834 | D | A |
| 23 Feb, 2026 | Jeff E. Knight | Common Stock | A | 34,000 | $0.00 | 121,929 | D | A |